637 related articles for article (PubMed ID: 18155564)
1. How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients.
Goh BK; Tan YM; Thng CH; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
J Am Coll Surg; 2008 Jan; 206(1):17-27. PubMed ID: 18155564
[TBL] [Abstract][Full Text] [Related]
2. Cystic neoplasms of the pancreas: problems in differential diagnosis.
Sperti C; Cappellazzo F; Pasquali C; Militello C; Catalini S; Bonadimani B; Pedrazzoli S
Am Surg; 1993 Nov; 59(11):740-5. PubMed ID: 7694532
[TBL] [Abstract][Full Text] [Related]
3. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years.
Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
Am J Surg; 2006 Aug; 192(2):148-54. PubMed ID: 16860621
[TBL] [Abstract][Full Text] [Related]
4. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.
Goh BK; Tan DM; Thng CH; Lee SY; Low AS; Chan CY; Wong JS; Lee VT; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
Ann Surg Oncol; 2014 Jun; 21(6):1919-26. PubMed ID: 24504924
[TBL] [Abstract][Full Text] [Related]
5. Non-neoplastic cystic and cystic-like lesions of the pancreas: may mimic pancreatic cystic neoplasms.
Goh BK; Tan YM; Chung YF; Chow PK; Ong HS; Lim DT; Wong WK; Ooi LL
ANZ J Surg; 2006 May; 76(5):325-31. PubMed ID: 16768691
[TBL] [Abstract][Full Text] [Related]
6. Is there an indication for initial conservative management of pancreatic cystic lesions?
Grobmyer SR; Cance WG; Copeland EM; Vogel SB; Hochwald SN
J Surg Oncol; 2009 Oct; 100(5):372-4. PubMed ID: 19267387
[TBL] [Abstract][Full Text] [Related]
7. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively.
Yamaguchi K; Ogawa Y; Chijiiwa K; Tanaka M
Am J Surg; 1996 Apr; 171(4):427-31. PubMed ID: 8604836
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
9. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
[TBL] [Abstract][Full Text] [Related]
10. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.
Sawhney MS; Al-Bashir S; Cury MS; Brown A; Chuttani R; Pleskow DK; Callery MP; Vollmer CM
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1373-6. PubMed ID: 19577006
[TBL] [Abstract][Full Text] [Related]
11. Cystic pancreatic tumors (CPT): predictors of malignant behavior.
Javle M; Shah P; Yu J; Bhagat V; Litwin A; Iyer R; Gibbs J
J Surg Oncol; 2007 Mar; 95(3):221-8. PubMed ID: 17323335
[TBL] [Abstract][Full Text] [Related]
12. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
Bloomston M; Bekaii-Saab TS; Kosuri K; Cowgill SM; Melvin WS; Ellison EC; Muscarella P
Pancreas; 2006 Oct; 33(3):246-9. PubMed ID: 17003645
[TBL] [Abstract][Full Text] [Related]
13. Management of suspected pancreatic cystic neoplasms based on cyst size.
Walsh RM; Vogt DP; Henderson JM; Hirose K; Mason T; Bencsath K; Hammel J; Brown N
Surgery; 2008 Oct; 144(4):677-84; discussion 684-5. PubMed ID: 18847654
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound and computer tomography are inaccurate methods of classifying cystic pancreatic lesions.
Gerke H; Jaffe TA; Mitchell RM; Byrne MF; Stiffler HL; Branch MS; Baillie J; Jowell PS
Dig Liver Dis; 2006 Jan; 38(1):39-44. PubMed ID: 16314152
[TBL] [Abstract][Full Text] [Related]
15. Lymphoepithelial cyst of the pancreas associated with elevated CA 19-9 levels.
Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D
J Hepatobiliary Pancreat Surg; 2008; 15(6):652-4. PubMed ID: 18987938
[TBL] [Abstract][Full Text] [Related]
16. Mucinous cystadenoma of the pancreas associated with acute pancreatitis and concurrent pancreatic pseudocyst.
Russell RT; Sharp KW
Am Surg; 2005 Apr; 71(4):292-7. PubMed ID: 15943401
[TBL] [Abstract][Full Text] [Related]
17. Malignant potential of solid pseudopapillary neoplasm of the pancreas.
Tipton SG; Smyrk TC; Sarr MG; Thompson GB
Br J Surg; 2006 Jun; 93(6):733-7. PubMed ID: 16609955
[TBL] [Abstract][Full Text] [Related]
18. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
20. Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.
Cerwenka H; Aigner R; Quehenberger F; Werkgartner G; Bacher H; Hauser H; Mischinger HJ
Hepatogastroenterology; 1997; 44(16):1117-21. PubMed ID: 9261609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
